At Shriners Hospitals for Children—Cincinnati, the health and safety of our patients, families, volunteers and staff is our top priority. With the rapidly evolving situation regarding coronavirus (COVID-19,) we are closely monitoring local health departments and The Centers for Disease Control and Prevention (CDC,) and are actively following their recommendations.

We are working diligently to reschedule appointments postponed during the quarantine. We also understand you may feel some anxiety about bringing your child into the hospital. Our plans to restart routine care have been thoughtfully developed and implemented to keep everyone safe. We are also scheduling some appointments for new patients. If you have any questions, please call the hospital at 855-206-2096.

Families that have appointments of any kind are asked to arrive with ONLY ONE parent or guardian and no additional family members or guests.

When you arrive for your appointment, if you and your child are not already wearing a mask, you will receive one. You will both be screened for illness and will notice new safety precautions in place to promote clean hands, a clean environment, and social distancing.

We are here for you, and look forward to seeing you soon.

Shriners Hospital for Children—Cincinnati researchers take top awards at international burn conference

osu

OSU(CINCINNATI, Ohio; April 16, 2019) – Researchers at Shriners Hospitals for Children—Cincinnati were awarded First and Second place Overall for two research projects aimed at improving burn treatment outcomes. The awards were presented at the 51st annual American Burn Association (ABA) conference, held April 2-5 in Las Vegas, Nevada.

The ABA annual conference highlights the latest developments in burn-related research, education, care, rehabilitation and prevention. There were 530 research abstracts from around the globe submitted for consideration, from which 292 were chosen for poster presentations at the conference. Cincinnati Shriners Hospital researchers won three Best in Category awards, two of which went on to take the First and Second place Overall.

The First-place Overall winning project, Combinatorial Use of CEAs with Dermal Substitutes Containing Dermal Papilla-like Structures, presented by Megan Malara, tested a new dermal graft material intended to improve outcomes for patients with large burns and insufficient non-burned skin for grafting. Cultured epithelial autograft (CEA) is a skin substitute used to speed wound closure in patients with very large burns, but it is thin and heals with more scarring than normal skin grafts. Preliminary findings show that the new dermal substitute, when combined with CEA, results in healed wounds that appear more like normal skin. Researchers on this project include Malara, Britani Blackstone, Molly Baumann, Danielle DeBruler, Kevin Bailey, Dorothy Supp and Heather Powell.

The Second-place Overall award, Pirfenidone Inhibits Epithelial-Mesenchymal Transition (EMT) Genes in Keloid Keratinocytes presented by Latha Satish, focused on a potential treatment to reduce keloid scarring. Keloids are abnormal scars that can grow indefinitely and have a negative impact on quality of life. Results indicated that a drug called Pirfenidone may make keloid scar cells behave more like normal skin cells. This early step could lead to discoveries to treat or even prevent keloid scars. Researchers on this project include Satish, Alexander Evdokiou, Jennifer Hahn and Dorothy Supp.

LathaPirfen

“I am proud to see the work of our scientific staff recognized at this prestigious meeting,” said Dorothy M. Supp, PhD, Interim Director of Research for Cincinnati Shriners Hospital. “These presentations exemplify the high quality of research performed by members of the Cincinnati Shriners Hospital scientific staff on a daily basis. These projects in particular offer the promise of improved treatments for patients with large burns or disfiguring scars.”

Translate »